Novartis

News

AI helping us make smarter, faster decisions, says Novartis ...

Novartis is trialling artificial intelligence (AI) in settings across drug discovery and drug development to help its scientists improve decision making.

News

Celgene to file potential MS blockbuster this year

Success with ozanimod would justify $7.2 billion outlay for Receptos.

News

Valeant's Siliq approved but suicidal thoughts warning will ...

But drug will have boxed warning over suicidal ideation.

News

Is BMS the next pharma takeover target?

Speculation mounting that Pfizer and others could try for $90 bn plus merger

News

Trump demands cuts to 'astronomical' drug prices - but pharm...

Trump calls pharma leaders to White House to discuss cutting taxes, regulations - and drug prices

News

Novartis' Votubia approved in childhood epilepsy

Votubia gets new indication.

AI helping us make smarter, faster decisions, says Novartis ...

Celgene to file potential MS blockbuster this year

Valeant's Siliq approved but suicidal thoughts warning will ...

Is BMS the next pharma takeover target?

Trump demands cuts to 'astronomical' drug prices - but pharm...

Novartis' Votubia approved in childhood epilepsy

AbbVie's migraine drug cleared for migraine attacks on NHS

Discover a new era of healthcare panel engagement: Grounded ...

Novartis

Editor's Picks